Home

Report

Rethinking Obesity: Impact of Novel Treatments on Healthcare Economics and Clinical Practice

Rethinking Obesity: Impact of Novel Treatments on Healthcare Economics and Clinical Practice

IQVIA
Pages 16 Pages

This report explores how new obesity therapies, particularly GLP-1–based treatments, are transforming clinical practice and healthcare economics. It reframes obesity as a chronic, multifactorial disease requiring long-term management. The analysis highlights implications for healthcare spending, provider roles, access challenges, and future research needs. As demand accelerates, the report stresses the importance of sustainable coverage models and coordinated care pathways.

Join for free to read

You Might Also Like


Rethinking Care Delivery
White Paper Rethinking Care Delivery
Omada

CDC Analysis of Extensive Data Sets and Insight into Obesity Trends and Related Health Issues
Case Study CDC Analysis of Extensive Data Sets and Insight into Obesity…
IQVIA

Mitigating Tariff Impact on US Healthcare Supply Chain
Guide Mitigating Tariff Impact on US Healthcare Supply Chain
KPMG

probiotics and Maternal Mental Health: A Randomised controlled trial among pregnant Women with obesity
Case Study probiotics and Maternal Mental Health: A Randomised controlled…
BMJ

More from IQVIA


CDC Analysis of Extensive Data Sets and Insight into Obesity Trends and Related Health Issues
Case Study CDC Analysis of Extensive Data Sets and Insight into Obesity…
IQVIA

India: Emerging Hub for Obesity Clinical Trials
White Paper India: Emerging Hub for Obesity Clinical Trials
IQVIA

Rethinking Clinical Trial Country Prioritization
Report Rethinking Clinical Trial Country Prioritization
IQVIA

From costly to cost-effective: rethinking commissioning of anti-obesity medications
White Paper From costly to cost-effective: rethinking commissioning of…
IQVIA
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info